The efficacy outcomes in non-small cell lung cancer patients treated with PD axis inhibitor agents - a population-based study of the Vojvodina region [0.03%]
程序性死亡受体信号通路抑制剂治疗非小细胞肺癌患者的有效性研究——一项基于伏伊伏丁那地区的队列研究
Nensi Lalić,Marko Bojović,Daliborka Bursać et al.
Nensi Lalić et al.
Background: By 2021, the FDA approved the use of the drugs pembrolizumab and atezolizumab in the first-line treatment of patients with high positivity of programmed death ligand-1 (PD-L1) in locally advanced and metastatic non-small-cell-lu...
From prenatal diagnosis to surgical treatment: two case reports of congenital granular cell epulis [0.03%]
从产前诊断至术后随访——两例先天性颗粒细胞息肉综合征报道
Yibing Han,Wen Qiu,Yu Zhang et al.
Yibing Han et al.
Herein, we detail a multidisciplinary approach and sequential treatment for two infants with congenital granular cell epulis (CGCE). Ultrasonic examinations at 34 weeks of gestation revealed prominent oral masses in both fetuses. To devise ...
Retraction: High expression of long noncoding RNA HOTAIRM1 is associated with the proliferation and migration in pancreatic ductal adenocarcinoma [0.03%]
撤稿：长链非编码RNA HOTAIRM1高表达与胰腺导管腺癌增殖和迁移有关
Pathology & Oncology Research Editorial Office
Pathology & Oncology Research Editorial Office
[This retracts the article DOI: 10.1007/s12253-018-00570-4.]. Copyright © 2024 Pathology & Oncology Research Editorial Office.
Retraction of Publication
Pathology oncology research : POR. 2024 Mar 4:30:1611728. DOI:10.3389/pore.2024.1611728 2024
Corrigendum: Association between pathological characteristics and recurrence score by OncotypeDX in resected T1-3 and N0-1 breast cancer: a real-life experience of a North Hungarian regional center [0.03%]
病理特征与OncoType DX复发评分在T1-3和N0-1乳腺癌切除标本中的相关性：匈牙利北部区域中心的单中心经验的更正公告
Dániel Deme,Bálint Ferenc Tamaskovics,Nizar Jammoul et al.
Dániel Deme et al.
[This corrects the article DOI: 10.3389/pore.2024.1611735.]. Keywords: OncotypeDX; breast cancer; observatio...
Published Erratum
Pathology oncology research : POR. 2024 Jul 8:30:1611862. DOI:10.3389/pore.2024.1611862 2024
Flow cytometry in the differential diagnosis of myelodysplastic neoplasm with low blasts and cytopenia of other causes [0.03%]
流式细胞术在低原始粒细胞比例骨髓增生异常肿瘤和其他原因引起的血细胞减少症鉴别诊断中的应用
Márk Plander,Mária Kányási,Tamás Szendrei et al.
Márk Plander et al.
Background: Myelodysplastic neoplasms (MDS) are characterized by cytopenia, morphologic dysplasia, and genetic abnormalities. Multiparameter flow cytometry (FCM) is recommended in the diagnostic work-up of suspected MDS, ...
The roles of phosphorylation of signaling proteins in the prognosis of acute myeloid leukemia [0.03%]
急性髓系白血病中信号传导蛋白磷酸化作用的预后作用研究
Adrienn Márton,Katalin Beáta Veres,Ferenc Erdődi et al.
Adrienn Márton et al.
Signaling pathways of Retinoblastoma (Rb) protein, Akt-kinase, and Erk-kinase (extracellular signal-regulated kinase) have an important role in the pathogenesis of acute myeloid leukemia. Constitutive activation of these proteins by phospho...
Attila Lieber,Attila Makai,Zsuzsanna Orosz et al.
Attila Lieber et al.
In the past decade we have seen new advances and thus remarkable progress in the therapeutic options for non-small cell lung cancer (NSCLC). Among cytostatic therapies with new approaches in molecularly targeted therapies, we see new develo...
Modified clock mapping biopsy sec. Della Corte-Bifulco in the preoperative assessment of excisional surgery for vulvar Paget's disease [0.03%]
改良的时钟映射活检（Della Corte-Bifulco法）在会阴部Paget病切除术前评估中的应用
Luigi Della Corte,Mario Ascione,Giuseppe Bifulco
Luigi Della Corte
We have developed a biopsy technique aimed at preoperative evaluating the extent of Paget's vulvar disease in order to plan subsequent radical vulvar surgery. The aim is to find all possible lesion sites that are not visible macroscopically...
Prognostic value of lung immune prognostic index in non-small cell lung cancer patients receiving immune checkpoint inhibitors: a meta-analysis [0.03%]
肺癌免疫预后指数在免疫检查点抑制剂治疗非小细胞肺癌患者中的预后价值：一项meta分析研究
Yi Wang,Yu Lei,Delai Zheng et al.
Yi Wang et al.
Background and purpose: Until now, it has been difficult to accurately predict the efficacy of immunotherapy in patients with non-small cell lung cancer (NSCLC). A novel indicator, the lung immune prognostic index (LIPI),...
Advancing neoadjuvant therapies in resectable non-small cell lung cancer: implications for novel treatment strategies and biomarker discovery [0.03%]
可切除非小细胞肺癌新辅助治疗的发展：新型治疗策略和生物标志物发现的启示
Hyein Jeon,Rajvi Gor,Angelica D&#x;Aiello et al.
Hyein Jeon et al.
The delivery of neoadjuvant and perioperative therapies for non-small cell lung cancer has been radically altered by significant advances and by the incorporation of targeted therapies as well as immune checkpoint inhibitors alone or alongs...